Azerbaijan National Academy of Sciences

The first drug in Russia against coronavirus infection COVID-19 - Avifavir produced by the Russian Direct Investment Fund (RDIF) and ChemRar - has received approval from the Ministry of Health, follows from information in the state registry of medicines.

"The trade name of the drug is Avifavir. The international non-proprietary or grouping or chemical name is Favipiravir," the registry says.

The drug has been well studied, since it has been in circulation in Japan since 2014 against severe forms of influenza.

Intermediate data from a clinical study of Avifavira confirm the high effectiveness of the drug for the treatment of COVID-19. The RDIF noted that the final stage of the Avifavir clinical trial, approved by the Ministry of Health on May 21, with the participation of 330 patients, is currently ongoing.

ria.ru